IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 17 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $12,000 | +50.0% | 58,540 | +81.4% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 32,270 | -4.0% | 0.00% | – |
| Q1 2018 | $8,000 | +14.3% | 33,627 | +55.7% | 0.00% | – |
| Q4 2017 | $7,000 | -56.2% | 21,592 | -51.0% | 0.00% | – |
| Q3 2017 | $16,000 | – | 44,088 | +35170.4% | 0.00% | – |
| Q2 2017 | $0 | – | 125 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 125 | -90.5% | 0.00% | – |
| Q4 2016 | $2,000 | – | 1,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 276,530 | $5,000 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Certified Advisory Corp | 20 | $0 | 0.00% |